Nepal - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Nepal Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases jumped by 9.4% year on year. In 2019, the country was ranked number 59 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases with 635 Cases. Nepal is overtaken by Turkmenistan, which was ranked number 58 at 649 Cases and is followed by Djibouti with 608 Cases. India ranked the highest with 66,255 Cases in 2019, an increase of 13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo witnessed the best average annual growth at +171.1% per year, while Croatia recorded the worst performance at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 635.00 |
| 2018 | 669.00 |
| 2017 | 533.00 |
| 2016 | 430.00 |
| 2015 | 451.00 |
How does Nepal rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 58 |
#58
Turkmenistan
|
649 | 2019 | +18.2 % | +25.4 % | View data | |
| 59 |
#59
Nepal
|
635 | 2019 | -5.1 % | +9.4 % | View data | |
| 60 |
#60
Djibouti
|
608 | 2019 | +807.5 % | +40.8 % | View data | |